BRCA2 and squamous cell carcinoma of penis: Despite the rarity of penile squamous cell carcinoma, BRCA1 and BRCA2 mutations were identified in both cases analyzed, suggesting homologous recombination deficiency and potential sensitivity to PARP inhibitors.